Patients at low risk of cardiovascular events (i.e. stable coronary artery disease and normal or slightly impaired left-ventricular function) do not benefit from ACE inhibitor therapy.

Background/Aim Use of ACE inhibitors (ACEIs) has been associated with an increased risk of cataract in a previous observational study in humans. In contrast, ACEIs were associated with beneficial ...

Effects of varying base-case estimates on the incremental cost–effectiveness ratio of treating all patients with advanced renal insufficiency with an ACE inhibitor versus no ACE inhibitor ...